Use of extracorporeal therapy in a dog with heatstroke

2021 ◽  
Author(s):  
Alyx Tracy ◽  
Alex Lynch ◽  
Kristen Messenger ◽  
Shelly Vaden ◽  
Alessio Vigani
Keyword(s):  
Extracorporeal Therapy

scholarly journals Extracorporeal therapy for patients in deep hypothermia

2018 ◽  
Vol 34 (4) ◽  
pp. 349-352
Author(s):  
Ewelina Nowak ◽  
Edward Pietrzyk ◽  
Agnieszka Saługa ◽  
Izabela Wojarska ◽  
Paweł Łytek ◽  
...  
Keyword(s):  
Deep Hypothermia ◽  
Extracorporeal Therapy

Sequential Extracorporeal Therapy Collaborative Device and Timely Support for Endotoxic, Septic, and Cardiac Shock: A Case Report

2019 ◽  
Vol 49 (4) ◽  
pp. 502-508 ◽  
Author(s):  
Silvia De Rosa ◽  
Sara Samoni ◽  
Claudio Ronco
Keyword(s):  
Septic Shock ◽  
Myocardial Dysfunction ◽  
Endotoxic Shock ◽  
Left Ventricular ◽  
Left Ventricular Ejection ◽  
Septic Cardiomyopathy ◽  
Ventricular Ejection Fraction ◽  
Circulatory Insufficiency ◽  
Extracorporeal Therapy ◽  
Va Ecmo

We report a 49-year-old man, without prior medical history, consulted in the emergency department with a 5 day history of cough, fever, and dysuria. He was admitted to the intensive care unit due to septic shock. Critical care management was initiated, including mechanical ventilation and vasopressors. Endotoxic shock was suspected (endotoxin activity assay [EAA] 0.75), and 2 treatments with Polymyxin B hemoperfusion (Toraymyxin®, Toray Medical Co., Ltd., Tokyo, Japan) were performed in 48 h, alternate with high-volume hemofiltration sessions. Initial blood cultures were positive for Neisseria meningitidis (serogroup B), and a lumbar puncture was deferred because of the coagulopathy and a bleeding risk. The circulatory efficiency significantly improved after the second procedure of hemoperfusion, and the treatment resulted in a marked decrease in the serum endotoxin level (EAA <0.4). However, after 48 h, tachycardia did not improve, left ventricular ejection fraction was 20%, and circulatory insufficiency progressed. Therefore, considering the involvement of septic cardiomyopathy and cardiogenic shock, veno-arterial extracorporeal membrane oxygenation (VA-ECMO) was initiated for circulation assistance on day 3 from admission. Continuous cytokine hemoadsorption (Cytosorb®, Cytosorbent Corporation, Monmouth Junction, NJ, USA) was incorporated into a VA-ECMO circuit for 48 h without a considerable improvement. For this reason, a 72-h continuous veno-venous hemodialysis session was started in which a high cutoff filter was used. Tachycardia and myocardial dysfunction improved by day 6, and VA-ECMO was withdrawn on the tenth day. Subsequently, nutrition management and rehabilitation were performed, and the patient was transferred to the department of respiratory medicine on day 80, he was discharged from our hospital on day 113. Sequential extracorporeal therapy may be beneficial when concomitant with circulatory assistance in uncontrollable cases of septic shock using catecholamines and blockers.

Solute Control in Acute Renal Failure: Prescription and Delivery of Adequate Extracorporeal Therapy

2007 ◽  
Vol 9 (2) ◽  
pp. 133-139 ◽  
Author(s):  
William R. Clark ◽  
Bruce A. Mueller ◽  
Michael A. Kraus ◽  
William L. Macias
Keyword(s):  
Renal Failure ◽  
Acute Renal Failure ◽  
Extracorporeal Therapy

Extracorporeal respiratory and cardiac support techniques in the ICU

2016 ◽  
Author(s):  
Claire Westrope ◽  
Giles Peek
Keyword(s):  
Cardiopulmonary Bypass ◽  
Lung Function ◽  
Cardiac Failure ◽  
Life Support ◽  
General Term ◽  
Swine Flu ◽  
Extra Corporeal Membrane Oxygenation ◽  
Temporary Support ◽  
Extracorporeal Therapy ◽  
Mechanical Devices

Extra corporeal life support (ECLS) is an essential tool for the modern intensivist and surgeon. The addition of extracorporeal therapy should be considered in all cases when pathology is potentially reversible and conventional therapy is clearly failing. ECLS is a general term to describe prolonged, but temporary support of heart and lung function using mechanical devices, which has developed as an extension of cardiopulmonary bypass techniques used in the operating theatre. Use in adult severe respiratory and cardiac failure is increasing following significant advances in ECLS techniques learnt from paediatric and neonatal experiences, and successful use of extra corporeal membrane oxygenation in the 2009 and 2001 H1N1 (swine flu) outbreaks. This chapter describes the techniques required for providing successful ECLS in adult respiratory and cardiac failure.

494: Functional Outcome After Hybrid Extracorporeal Therapy in Pediatric Liver Failure

2020 ◽  
Vol 49 (1) ◽  
pp. 238-238
Author(s):  
Kristin Dolan ◽  
Moreshwar Desai ◽  
Poyyapakkam Srivaths ◽  
Trung Nguyen ◽  
Sanjiv Harpavat ◽  
...  
Keyword(s):  
Liver Failure ◽  
Functional Outcome ◽  
Pediatric Liver ◽  
Extracorporeal Therapy

scholarly journals Antiviral Dosing Modification for Coronavirus Disease 2019–Infected Patients Receiving Extracorporeal Therapy

2020 ◽  
Vol 2 (10) ◽  
pp. e0242
Author(s):  
Weerachai Chaijamorn ◽  
Dhakrit Rungkitwattanakul ◽  
Nantana Nuchtavorn ◽  
Taniya Charoensareerat ◽  
Sutthiporn Pattharachayakul ◽  
...  
Keyword(s):  
Extracorporeal Therapy

scholarly journals Practice of Extracorporeal Therapies for Septic Acute Kidney Injury Patients in Intensive Care Units in Mainland China

2019 ◽  
Vol 47 (Suppl. 3) ◽  
pp. 23-28
Author(s):  
Yu Zhou ◽  
Fachun Zhou ◽  
Xue Wang ◽  
Ping Chang ◽  
Ling Zhang ◽  
...  
Keyword(s):  
Acute Kidney Injury ◽  
Intensive Care ◽  
Clinical Practice ◽  
Mainland China ◽  
Kidney Injury ◽  
Current Status ◽  
Major Objective ◽  
Septic Acute Kidney Injury ◽  
Extracorporeal Therapy ◽  
Icu Physicians

Background: Continuous renal replacement therapy (CRRT) and other extracorporeal therapies for acute kidney injury (AKI) and other organ dysfunction syndromes in critically ill patients are common in the intensive care unit (ICU). Many studies have focused on clinical practice for managing these conditions. However, there are few studies that describe the utilization of extracorporeal therapies, especially CRRT, in patients with sepsis-associated AKI. Summary: Two hundred ICU physicians were included in a survey from February 28, 2017, to March 20, 2017, on the current status of septic AKI and clinical practice in CRRT. According to the responses, 40% of sepsis patients in the ICU had AKI, and 25% required extracorporeal therapies. However, 29% of candidates gave up therapy for medical or nonmedical reasons. Overall survival for sepsis was 60%; among survivors, 80% were dialysis free at discharge. CRRT was the most common modality of extracorporeal therapy in the ICU, and 82% of physicians chose convection as the major clearance mode. The survey showed 30% of physicians saw the removal of inflammatory mediators as the major objective of extracorporeal therapies; however, only 18.5% of physicians considered inflammation as a measure to trigger CRRT. The median treatment duration of CRRT in China was 12 h per day for 5 days. Key Messages: There were some similarities and differences in CRRT practice for septic AKI patients in China and globally. The differences reveal some insights into improving the outcomes of these patients.

Sequential Blood Purification for Pediatric Fatal Toxic Epidermal Necrolysis: A Case Series

2021 ◽  
pp. 1-8
Author(s):  
Yun Cui ◽  
Jingyi Shi ◽  
Chunxia Wang ◽  
Yiping Zhou ◽  
Fei Wang ◽  
...  
Keyword(s):  
Toxic Epidermal Necrolysis ◽  
Case Series ◽  
Pediatric Intensive Care ◽  
Skin Lesions ◽  
Daily Basis ◽  
Multiple Organ ◽  
Continuous Hemofiltration ◽  
Unsuccessful Treatment ◽  
Number Of Patients ◽  
Extracorporeal Therapy

<b><i>Background:</i></b> Extracorporeal therapy that included therapeutic plasma exchange (TPE) or continuous hemofiltration (CHF) for toxic epidermal necrolysis (TEN) syndrome was used in small number of patients. We aimed to describe the sequential mode of combined application of CHF and TPE in 3 TEN patients with multiple organ dysfunction (MODS) in pediatric intensive care unit. <b><i>Methods:</i></b> Three patients with fatal TEN received sequential CHF and TPE due to unsatisfactorily conventional treatments. CHF was initiated and performed on a daily basis with 35–50 mL/kg.h replacement fluid at the rate of 3–5 mL/kg.min blood flow. CHF was temporarily interrupted for TPE, which was performed with exchange 1–1.5-fold of one body calculated plasma volume in each section. <b><i>Results:</i></b> All 3 fatal TEN (with &#x3e;30% involvement of body surface and MODS) following unsuccessful treatment with corticosteroids and intravenous immunoglobulin. Antibiotics were suspected in the TEN-triggered drugs. The range number of TPE sessions was 3–5 and the duration of CHF was from 120 h to 202 h. After initiation of TPE and CHF, blistering with extensive epidermal necrosis halted and the skin re-epithelialized within 2 weeks. Serum C-reactive protein, procalcitonin, tumor necrosis factor-α , and interlukin-6 decreased and percentage of natural killer cells increased in surviving children. Two patients survived to discharge and one case died due to nosocomial infection with multidrug-resistant <i>Acinetobacter baumannii.</i> <b><i>Conclusion:</i></b> After sequential TPE and CHF, skin lesions and inflammatory response improved in TEN. Our result indicates extracorporeal therapy could be used as an alternative modality for fatal pediatric TEN.

Sign in / Sign up

Export Citation Format

Share Document